Pharmacodynamics explains how drugs affect the body and how the size of a dose relates to the size of a response. This cheat sheet helps students read dose-response graphs, compare drugs, and understand important safety measures. It is useful for connecting biology, chemistry, and medical science concepts in a clear reference format.
The most important ideas are potency, efficacy, EC50, ED50, TD50, and therapeutic index. A graded dose-response curve shows how one patient or tissue responds as dose increases, while a quantal curve shows the percent of a population that reaches a defined effect. Safer drugs usually have a wider therapeutic window and a larger therapeutic index.
Key Facts
- Emax is the maximum effect a drug can produce, no matter how much more dose is given.
- EC50 is the concentration that produces 50% of the drug's maximum effect in a graded dose-response curve.
- ED50 is the dose that produces the desired effect in 50% of a population in a quantal dose-response curve.
- TD50 is the dose that produces a toxic effect in 50% of a population.
- Therapeutic index is calculated as TI = TD50 / ED50, and a larger TI usually means a safer drug.
- Potency compares how much drug is needed for an effect, so a lower EC50 or ED50 means higher potency.
- Efficacy compares the maximum effect of drugs, so the drug with the higher Emax has greater efficacy.
- A competitive antagonist shifts the dose-response curve to the right and increases EC50 without lowering Emax if enough agonist is present.
Vocabulary
- Pharmacodynamics
- The study of what a drug does to the body, including its effects, mechanisms, and dose-response relationship.
- Dose-response curve
- A graph that shows how the response to a drug changes as the dose or concentration increases.
- Potency
- A measure of how much drug is needed to produce a given effect, often compared using EC50 or ED50.
- Efficacy
- The maximum effect a drug can produce, often represented by Emax on a dose-response graph.
- Therapeutic window
- The range of drug doses or concentrations that is likely to be effective without causing unacceptable toxicity.
- Agonist
- A drug or molecule that binds to a receptor and activates it to produce a biological response.
Common Mistakes to Avoid
- Confusing potency with efficacy is wrong because potency describes dose needed, while efficacy describes maximum effect.
- Assuming a higher dose always gives a stronger response is wrong because responses can plateau at Emax when receptors or pathways are saturated.
- Reading EC50 as the dose for 50% of people is wrong because EC50 applies to a graded response, while ED50 applies to a population response.
- Treating a small therapeutic index as safer is wrong because TI = TD50 / ED50, and a small value means toxic and effective doses are close together.
- Ignoring the axis scale on dose-response graphs is wrong because many pharmacology graphs use a logarithmic dose axis, which changes how spacing should be interpreted.
Practice Questions
- 1 Drug A has an EC50 of 2 mg/L and Drug B has an EC50 of 10 mg/L. Which drug is more potent, and why?
- 2 A medication has an ED50 of 25 mg and a TD50 of 200 mg. Calculate the therapeutic index using TI = TD50 / ED50.
- 3 On a graded dose-response curve, Drug X reaches an Emax of 90 units and Drug Y reaches an Emax of 60 units. Which drug has greater efficacy?
- 4 A competitive antagonist shifts an agonist dose-response curve to the right without lowering Emax. Explain what this means for potency and maximum effect.
Understanding Pharmacodynamics Dose-Response Reference
Drug effects begin when molecules reach targets such as receptors, enzymes, ion channels, or transport proteins. A drug molecule must first arrive at the target site in a high enough concentration. It then binds for a limited time and changes cell activity.
Some drugs turn a receptor on. Others block a natural signal or reduce its activity. The measured response may be muscle contraction, lower blood pressure, reduced pain, slower bacterial growth, or a laboratory value.
The link between receptor binding and visible effect is not always direct. Cells can amplify a small signal through chemical pathways, so a strong response can occur before every receptor is occupied. These unused receptors are often called spare receptors.
The shape of a dose-response curve carries useful information. Graphs commonly use a logarithmic dose scale because drug doses may differ by factors of ten or more. This spreads out the middle part of the curve, where comparisons are easiest.
A steep curve means that a small dose increase can cause a large change in response. That can make dose selection more difficult. A shallow curve gives a wider range over which the response changes gradually.
The flat upper region does not mean the drug has stopped entering the body. It means the measured system has reached its limit. Giving more drug beyond this point may mainly increase unwanted effects.
A drug can bind well to a receptor yet produce only a limited response. Such a drug is called a partial agonist. In a system with a full agonist present, a partial agonist can reduce the overall effect because it occupies receptors that the full agonist could have activated more strongly.
Antagonists have no activating effect by themselves, but they can prevent agonists from working. A competitive antagonist competes at the same binding site. Its effect can sometimes be overcome by raising agonist concentration.
A noncompetitive antagonist reduces signaling in a way that cannot be fully overcome, often lowering the maximum response. These differences help explain why two drugs aimed at the same receptor may behave very differently.
Population data need careful interpretation because people do not respond identically. Age, body mass, genetics, kidney function, liver function, illness, food intake, and other medicines can change the concentration that reaches a target. A population graph depends on how the outcome is defined.
For example, a study might count a certain drop in blood pressure as a successful response. Changing that definition changes the curve. Toxic effects are often different from the intended effect and may occur through different targets.
A safety ratio is therefore a useful warning sign, not a promise that one dose is safe for every person. In real prescribing, clinicians begin with evidence from studies, consider the individual patient, monitor results, then adjust treatment carefully. Students should keep concentration, dose, response, and population percentage separate when reading any graph.